Business Risks of Selling Moldy Weed

A batch that fails microbial testing is a problem you can still fix. A batch that clears the lab, reaches a dispensary, and turns moldy on the shelf is a problem with your name on it.

In 2024, a Massachusetts MSO was fined $200K for selling moldy weed, and the case came to light through its own employees, backed by complaints from patients and consumers. This page is written for the operator whose license, retail accounts, and brand sit behind every flower product that leaves their operations.

Moldy weed that reaches a dispensary shelf puts four things in play at once: the people who buy it, the people who handle it, the credibility of your state's cannabis program, and your revenue. Federal status, taxes, and a crowded shelf are mostly out of your hands. What leaves your facility isn't.

The business risks of selling moldy weed come down to public health advisories and recalls, lost retail accounts, tighter oversight for everyone licensed in your state, worker exposure claims, and flower that must be destroyed or sold at a steep discount. Most of that exposure shrinks once a validated microbial kill step runs on every batch before it's sampled.

Risks to Your Customers

Aspergillus is the name to know. It is screened in essentially every US state, and certain species can cause severe respiratory infections when inhaled, including aspergillosis in people with weakened immune systems. California’s Department of Cannabis Control had issued 21 cannabis recalls citing aspergillus by the end of August 2024, five of them that month alone.

Most strains of this common mold are harmless. That’s the fair read, and it doesn’t soften the business picture, because those recalls were issued on the presence of Aspergillus alone.

For most healthy adults, smoking moldy flower means coughing, congestion, maybe nausea. People with mold allergies can develop sinus and lung inflammation. Patients with weakened immune systems, who use your flower as medicine, are the ones most at risk.

If your market is medical, the stakes climb, since patients and regulators both expect clean flower. And a clean certificate of analysis doesn’t close the question. Mold can develop after testing when packaging, shipping, or storage goes wrong, so a batch that passed on paper can still reach a patient carrying it.

Risks to Your Employees

Your staff meets the mold before any customer does.

Employees exposed to moldy cannabis can develop coughing, congestion, sneezing, wheezing, and nausea. Mold also travels with their work. Unclean scissors, gloves, bins, and trays carry spores from one plant to the next and from one room to another, and bud rot is hard to catch in the trim room, since it starts inside dense colas and works outward toward the surface.

Staff also see what happens to a failed batch. One Massachusetts cannabis worker told GBH News about being instructed by a supervisor to “pick the moldy pieces off” and put the rest into an eighth container to be sold. A kill step changes what everyone downstream of it handles, from packaging staff to budtenders, and it takes that kind of instruction off the table. Retaining staff after a state health advisory can be difficult.

Risks to Your State's Program

Massachusetts testing labs spent years warning regulators, with hundreds of data points, that moldy cannabis was being sold. A consumer advisory in February 2025 finally acknowledged the problem. In Colorado, an investigation into 325,000 mold tests by The Denver Gazette found an unusual cluster of results sitting just under the legal limit, a sign that some numbers were being nudged to pass, and some companies were remediating only the samples they sent to the lab while selling the rest of the batch untreated and untested.

Stories like these don’t stay with one licensee. Reporters covered both states, and the questions landed on the regulators, which is how one operator’s shortcut becomes everyone’s problem.

Public pressure on a regulator turns into stricter rules for operators who did nothing wrong. New Jersey shows what tighter looks like. In early 2025 it capped test batches at 33.07 pounds instead of 100, ended lab shopping, and standardized lab protocols for pesticides, heavy metals, and mold, and every licensee in the state now works under those rules. A state program runs on the trust of patients, consumers, and the people who work in it. Once that trust slips, every license holder pays.

The federal side is moving as well. In April 2026 the Justice Department moved state-licensed medical cannabis to Schedule III, while recreational cannabis stayed in Schedule I. A DEA hearing on rescheduling all cannabis wrapped in July 2026, and the judge's recommendation is still pending. How federal agencies will treat product contamination is still an open question. Our read is that a product inside a federal schedule draws more scrutiny over time, and an operator with a documented kill step will have an easier conversation when it arrives.

Risks to Your Bottom Line

A dispensary buyer has plenty of other brands to stock. So does the customer who opens an eighth and sees fuzz.

Colorado shows how far one failure travels. In February 2026, the state’s Department of Revenue and Department of Public Health and Environment issued a health and safety advisory for one cultivator’s flower over total yeast, mold, and Aspergillus, and the advisory listed 31 stores that had sold it. That’s 31 retail relationships touched by one problem, each with a fresh reason to hesitate over the next purchase order.

The revenue math is blunt. In a Michigan example we modeled at Ziel, recreational flower is valued at $2,500 to $3,000 a pound, while flower that fails testing and gets sold as trim brings about $500 a pound. Good SOPs help, and they still leave a wide spread. Mold is present at some level in nearly any facility, and operators relying on SOPs without a kill step see pass rates anywhere from 50% to 99%, swinging with the season, cross-contamination, drying, and handling.

"A brand recall is death," says Arthur de Cordova, Ziel's CEO and co-founder. A recall is costly and damaging to the brand, and if the state revokes your license, it can end the business outright.

The Most Cost-Effective Strategy for Decontaminating Cannabis

Two families of technology do most of the microbial reduction in licensed cannabis. One is ionizing, the other isn't, and the difference follows the flower all the way to market.

Gamma, electron beam, and x-ray are ionizing. They use high-energy wavelengths that strip electrons from atoms in the flower, which kills microbes and alters the plant at the molecular level along the way. The practical costs cluster around the treatment itself. Gamma and e-beam run off-site, so you pay for transport, insurance, and chain of custody; X-ray can run in-house but brings licensing and facility infrastructure. Ionizing treatment also disqualifies an organic claim.

Radio frequency is non-ionizing. Long, low-energy wavelengths set the water molecules inside the bud rotating about 27 million times per second, and that friction produces enough heat to kill mold, yeast, and pathogens without degrading or decarbing THC. The heat builds through the whole bud rather than on its surface, so it reaches the core, where bud rot sits. RF is compliant with organic processes.

Cost per pound tracks the same split. Our 10-year levelized cost model, built on RF and x-ray systems installed side by side at one US multi-state operator, puts RF at $3.23 per pound against $6.28 to $10.87 for x-ray, depending on the incoming microbial load. Off-site gamma or e-beam runs roughly $20 to $30 a pound. Per shift, RF moves about three times the volume x-ray does.

Any kill step has limits, RF included, and they’re worth knowing before a failed certificate lands. Pesticides and heavy metals are untouched by it. Powdery mildew is the other one: no remediation process removes it, so the visible damage stays on the flower.

Radio Frequency Decontamination With the Ziel RFX

The Ziel RFX was built for volume. One unit processes up to 160 pounds of flower or 200 pounds of milled product in an eight-hour shift, runs around the clock with no rest between cycles, and works on single-phase power. Installation, commissioning, and training wrap up in four days.

Batches treated with the RFX pass regulatory compliance more than 99% of the time. The process cuts Total Yeast and Mold Count by more than 99.9%, a 3-log reduction, and in 99% of cases leaves the sensory qualities of the flower unchanged.

The machine also logs data on each batch it runs. Over a few harvests that record shows which strains are more prone to mold, whether post-harvest SOPs are being followed, and when a product is likely to fail testing, before a sample ever leaves the building.

A Kill Step on Every Batch Changes the Math

Put the kill step between trimming and testing on every batch, and the judgment call disappears from each harvest. The batch is treated before it’s sampled, and a failed certificate of analysis stops being the thing that decides your quarter.

If you want to see what radio frequency would recover for your operation, or you have a moldy batch in front of you right now, get in touch with our team at Ziel.